Genetic scissors snip away at sickle cell.
The first CRISPR gene editing therapy has been approved to treat sickle cell disease, heralding a new era of transformative genomic medicine. By precisely editing a single gene in a patient's stem cells, scientists can override the mutation that causes debilitating sickle cell pain crises. Though complex and costly at $2 million per treatment, the approach offers hope of a "one-and-done" cure and could pave the way for treating numerous other genetic diseases.
Read the full article on Wired.
----
💡 We're entering a world where intelligence is synthetic, reality is augmented, and the rules are being rewritten in front of our eyes.
Staying up-to-date in a fast-changing world is vital. That is why I have launched Futurwise; a personalized AI platform that transforms information chaos into strategic clarity. With one click, users can bookmark and summarize any article, report, or video in seconds, tailored to their tone, interests, and language. Visit Futurwise.com to get started for free!
Dr Mark van Rijmenam
Dr. Mark van Rijmenam, widely known as The Digital Speaker, isn’t just a #1-ranked global futurist; he’s an Architect of Tomorrow who fuses visionary ideas with real-world ROI. As a global keynote speaker, Global Speaking Fellow, recognized Global Guru Futurist, and 5-time author, he ignites Fortune 500 leaders and governments worldwide to harness emerging tech for tangible growth.
Recognized by Salesforce as one of 16 must-know AI influencers , Dr. Mark brings a balanced, optimistic-dystopian edge to his insights—pushing boundaries without losing sight of ethical innovation. From pioneering the use of a digital twin to spearheading his next-gen media platform Futurwise, he doesn’t just talk about AI and the future—he lives it, inspiring audiences to take bold action. You can reach his digital twin via WhatsApp at: +1 (830) 463-6967.
